Comprehensive NGS-Based Testing for Transplant Compatibility, Monitoring & Immune Profiling
The IVDNGS™ Extended Transplant Panel is a high-resolution, Next-Generation Sequencing (NGS) assay developed for accurate histocompatibility testing, immune monitoring, and post-transplant surveillance. Designed for in vitro diagnostic use, this panel enables precise HLA typing, donor-recipient matching, and detection of gene variants related to transplant rejection risks, infections, and immune complications.
It is suitable for solid organ and hematopoietic stem cell transplantation, ensuring improved outcomes through deeper genomic insight.
High-throughput NGS-based analysis of HLA Class I & II loci
Includes immune response genes, cytokines, drug metabolism markers
Detects SNPs, indels, and clinically relevant polymorphisms
Enables donor-recipient compatibility assessment
Supports monitoring of graft tolerance, rejection risk, and drug response
Developed under IVD compliance and ISO 13485 standards
Pre-transplant HLA typing & donor matching
Risk assessment of rejection & graft-versus-host disease (GVHD)
Post-transplant immune monitoring
Personalized immunosuppressive therapy selection
Research in transplant genomics and outcomes
| Parameter | Details |
|---|---|
| Sample Type | EDTA blood, buffy coat, saliva |
| DNA Input | 10–50 ng |
| Turnaround Time | 3–5 working days |
| Output | Variant report, HLA typing, CNV/SNP |
| Compatibility | Illumina NGS platforms |
Copyright © 2025 https://probgenbiotech.com/ All Rights Reserved.